VETRANO, STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 3.042
AS - Asia 1.321
EU - Europa 647
SA - Sud America 487
AF - Africa 101
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 5.604
Nazione #
US - Stati Uniti d'America 2.976
SG - Singapore 746
BR - Brasile 431
CN - Cina 290
FI - Finlandia 158
VN - Vietnam 102
IT - Italia 95
DE - Germania 83
IE - Irlanda 79
NG - Nigeria 68
FR - Francia 52
SE - Svezia 38
CA - Canada 37
HK - Hong Kong 37
IN - India 37
NL - Olanda 31
GB - Regno Unito 30
AR - Argentina 17
MX - Messico 15
EC - Ecuador 14
TR - Turchia 14
BD - Bangladesh 13
BE - Belgio 13
JP - Giappone 13
RU - Federazione Russa 13
ZA - Sudafrica 12
IL - Israele 11
ID - Indonesia 10
PL - Polonia 10
ES - Italia 8
IQ - Iraq 7
PY - Paraguay 7
PK - Pakistan 6
UA - Ucraina 6
CL - Cile 5
DO - Repubblica Dominicana 5
MA - Marocco 5
SA - Arabia Saudita 5
VE - Venezuela 5
CO - Colombia 4
EG - Egitto 4
KG - Kirghizistan 4
LT - Lituania 4
RO - Romania 4
CZ - Repubblica Ceca 3
DZ - Algeria 3
JM - Giamaica 3
KZ - Kazakistan 3
TN - Tunisia 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AT - Austria 2
AU - Australia 2
CH - Svizzera 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
EE - Estonia 2
GE - Georgia 2
HN - Honduras 2
IR - Iran 2
JO - Giordania 2
KE - Kenya 2
LB - Libano 2
MD - Moldavia 2
NO - Norvegia 2
NP - Nepal 2
PE - Perù 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CY - Cipro 1
DK - Danimarca 1
EU - Europa 1
GA - Gabon 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
MK - Macedonia 1
MU - Mauritius 1
MY - Malesia 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TO - Tonga 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 5.604
Città #
Wilmington 429
Chandler 388
Singapore 290
Dallas 207
The Dalles 201
Ashburn 177
Helsinki 156
San Mateo 145
Shanghai 141
Ann Arbor 128
Boardman 96
Beijing 91
Leawood 81
Dublin 79
Lawrence 77
Princeton 77
Benin City 68
New York 58
Paris 51
Ho Chi Minh City 44
Fairfield 39
Hong Kong 37
Woodbridge 37
Los Angeles 30
Milan 29
Amsterdam 28
São Paulo 28
Toronto 26
Hanoi 23
Seattle 23
Abbiategrasso 21
Columbus 19
Council Bluffs 19
Pune 16
London 14
Naples 14
Phoenix 14
Brussels 13
Chicago 13
Rio de Janeiro 13
Munich 12
Curitiba 11
Belo Horizonte 10
Norwalk 10
Santa Clara 10
Warsaw 10
Brooklyn 9
Boston 8
Brasília 8
Frankfurt am Main 8
Porto Alegre 8
San Francisco 8
San Diego 7
Tokyo 7
Assago 6
Denver 6
Guayaquil 6
Houston 6
Kocaeli 6
Atlanta 5
Campinas 5
Charlotte 5
Duque de Caxias 5
Johannesburg 5
Mexico City 5
Bishkek 4
Chennai 4
Feira de Santana 4
Fortaleza 4
Jakarta 4
Monmouth Junction 4
Montreal 4
Ribeirão Preto 4
São José 4
Volta Redonda 4
Alexandria 3
Asunción 3
Betim 3
Blumenau 3
Catanduva 3
Charleston 3
Chengdu 3
Ciudad del Este 3
Da Nang 3
Dracena 3
Falkenstein 3
Falls Church 3
Giussano 3
Gunzenhausen 3
Hangzhou 3
Hải Dương 3
Irkutsk 3
Kingston 3
Manaus 3
Mumbai 3
Newark 3
Nova Friburgo 3
Osaka 3
Osasco 3
Quito 3
Totale 3.741
Nome #
Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer 132
Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response 127
The urokinase plasminogen activator receptor (uPAR) controls macrophage phagocytosis in intestinal inflammation 110
Unique role of junctional adhesion molecule-A in maintaining mucosal homeostasis in inflammatory bowel disease 98
Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease 97
Colitis-associated cancer: the dark side of inflammatory bowel disease 94
New insights into inflammatory bowel disease pathophysiology: Paving the way for novel therapeutic targets 92
Narrow-band imaging endoscopy to assess mucosal angiogenesis in inflammatory bowel disease: a pilot study 92
Colifagina, a novel preparation of 8 lysed bacteria ameliorates experimental colitis 91
VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis 86
Protumor Steering of Cancer Inflammation by p50 NF-κB Enhances Colorectal Cancer Progression 85
mTOR-Dependent Stimulation of IL20RA Orchestrates Immune Cell Trafficking through Lymphatic Endothelium in Patients with Crohn's Disease 83
Effect of Immunosuppression on Immune Response to Pneumococcal Vaccine in Inflammatory Bowel Disease: A Prospective Study 82
VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease 81
Centrally Determined Standardization of Flow Cytometry Methods Reduces Interlaboratory Variation in a Prospective Multicenter Study 78
The bacterial sensor Triggering Receptor Expressed on Myeloid cells 2 (TREM-2) is a crucial pathogenic mediator in inflammatory bowel disease (IBD) 77
Critical role of the CD40-CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease 77
Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease 76
MFSD2A Promotes Endothelial Generation of Inflammation-resolving Lipid Mediators and Reduces Colitis in Mice 76
Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease : a prospective study 76
Contrast-enhancement at magnetic resonance enterography does not differentiate between fibrosis and inflammation in Crohn's disease: a prospective cohort study 75
Colitis, microbiota and colon cancer: an infernal triangle 75
Enhanced platelet adhesion induces angiogenesis in intestinal inflammation and inflammatory bowel disease microvasculature 73
Cathelicidins: A Novel Therapy for the Treatment of Intestinal Fibrosis 71
Effect of Tumor Necrosis Factor-alpha Blockade on Mucosal Addressin Cell-adhesion Molecule-1 in Crohn's Disease 70
Anti-TNF Antibodies and Autophagy: A Hidden Nexus for a Successful Therapeutic Response? 70
RISK OF MICROBIAL TRANSLOCATION IN PATIENTS UNDERGOING PER-ORAL ENDOSCOPIC MYOTOMY FOR ACHALASIA. PRELIMINARY RESULTS 69
Antiendomysial antibody detection in fecal supernatants: In vivo proof that small bowel mucosa is the site of antiendomysial antibody production 69
Detection of anti-endomysial and anti-tissue transglutaminase autoantibodies in media following culture of oral biopsies from patients with untreated coeliac disease 69
OP018 High-fat diet and inflammation drive intestinal fibrosis enhancing epithelial–mesenchymal transition through the activation of S1P3 signalling 67
Infliximab Inhibits Mucosal Pathological Angiogenesis in Crohn's Disease 67
A Small CEACAM5 Peptide Restores the Protective Function of CD8+ Regulatory T Cells in Crohn's Disease 66
Mesenchymal Stem Cells to Treat Digestive System Disorders: Progress Made and Future Directions 66
JAK-STAT Pathway Targeting for the Treatment of Inflammatory Bowel Disease 66
Multiple pathogenic roles of microvasculature in inflammatory bowel disease : a Jack of all trades 65
The protein C pathway in tissue inflammation and injury: pathogenic role and therapeutic implications 64
NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high antitumor activity against colorectal cancer 64
Unexpected role of anticoagulant protein C in controlling epithelial barrier integrity and intestinal inflammation. 64
Mesenchymal stromal cells in inflammatory bowel disease: conspirators within the 'colitogenic niche'? 63
Anti-endomysial antibody of IgG1 isotype detection strongly increases the prevalence of coeliac disease in patients affected by type I diabetes mellitus 63
The Multiple Faces of Integrin-ECM Interactions in Inflammatory Bowel Disease 63
Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease 62
STIMULATION OF CYP450-MEDIATED omega-3 DOCOSAHEXAENOIC ACID (DHA) METABOLISM VIA MFSD2A AS A NOVEL THERAPY FOR INFLAMMATORY BOWEL DISEASE 62
Targeting S1P in Inflammatory Bowel Disease: New Avenues for Modulating Intestinal Leukocyte Migration 61
The role of MAPK in governing lymphocyte adhesion to and migration across the microvasculature in inflammatory bowel disease 61
Lymphatic endothelium contributes to colorectal cancer growth via the soluble matrisome component GDF11 61
The Microglial Innate Immune Receptor TREM2 Is Required for Synapse Elimination and Normal Brain Connectivity. 60
Involvement of CD40-CD40 Ligand in Uncomplicated and Refractory Celiac Disease 60
Stimulation of CYP450-mediated omega-3 docosahexaenoic acid metabolism via MFSD2A as a novel therapy for inflammatory bowel disease 60
Rho-A prenylation and signaling link epithelial homeostasis to intestinal inflammation 59
Sealing the broken barrier in IBD: intestinal permeability, epithelial cells and junctions 59
The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6 58
Infliximab therapy inhibits inflammation-induced angiogenesis in the mucosa of patients with Crohn's disease 57
Unveiling role of sphingosine-1-phosphate receptor 2 as a brake of epithelial stem cell proliferation and a tumor suppressor in colorectal cancer 57
The IL23-IL17 Immune Axis in the Treatment of Ulcerative Colitis: Successes, Defeats, and Ongoing Challenges 57
Dysfunctional Extracellular Matrix Remodeling Supports Perianal Fistulizing Crohn's Disease by a Mechanoregulated Activation of the Epithelial-to-Mesenchymal Transition 56
The Role of JAM-A in Inflammatory Bowel Disease: Unrevealing the Ties That Bind 56
Usefulness of the organ culture system in the in vitro diagnosis of coeliac disease: A multicentre study 56
Intestinal myofibroblast-specific Tpl2-Cox-2-PGE(2) pathway links innate sensing to epithelial homeostasis 54
The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6 54
Journey through Crohn's Disease Complication: From Fistula Formation to Future Therapies 54
TNF-stimulated gene-6 (TSG-6) is a key regulator in switching stemness and biological properties of mesenchymal stem cells 53
Single-dose versus short-course prophylactic antibiotics for peroral endoscopic myotomy: a randomized controlled trial 53
Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine 52
The atypical chemokine receptor D6 controls intestinal inflammation and inflammation-associated colon cancer 52
Stimulation of CYP450-mediated ω-3 docosahexaenoic acid metabolism via MFSD2A as a novel therapy for inflammatory bowel disease 51
Antiendomysial Antibody Detection in Biopsy Culture Allows Avoidance of Gluten Challenge in Celiac Children 50
The protein C pathway in intestinal barrier function: challenging the hemostasis paradigm 49
Patient-derived tumor models: a more suitable tool for pre-clinical studies in colorectal cancer 49
Dynamic changes in extracellular vesicle-associated miRNAs elicited by ultrasound in inflammatory bowel disease patients 48
Mesenchymal Stem Cells in IBD: unMaSCing Their Therapeutic Mechanisms 48
Hyaluronan Accelerates Intestinal Mucosal Healing through Interaction with TSG-6 48
Tumor-associated macrophages and risk of recurrence in stage III colorectal cancer 48
Proceedings of the signature series event of the international society for cellular therapy: "Advancements in cellular therapies and regenerative medicine in digestive diseases," London, United Kingdom, May 3, 2017 47
GPR120 prevents colorectal adenocarcinoma progression by sustaining the mucosal barrier integrity 47
In vitro Anti-inflammatory and Protective Effects of ibidì® on Intestinal Epithelial Cells 46
Programming of Intestinal Epithelial Differentiation by IL-33 Derived from Pericryptal Fibroblasts in Response to Systemic Infection 45
Reciprocal influence of B cells and tumor macro and microenvironments in the ApcMin/+ model of colorectal cancer 45
Endothelial Tpl2 regulates vascular barrier function via JNK-mediated degradation of claudin-5 promoting neuroinflammation or tumor metastasis 45
Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel 43
Anti-Tissue Transglutaminase Antibodies in Arthritic Patients: A Disease-specific Finding? 41
Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor 39
Pomegranate Extract Affects Gut Biofilm Forming Bacteria and Promotes Intestinal Mucosal Healing Regulating the Crosstalk between Epithelial Cells and Intestinal Fibroblasts 38
ImmUniverse Consortium: Multi-omics integrative approach in personalized medicine for immune-mediated inflammatory diseases 37
The Inflammatory Bowel Disease Transcriptome and Metatranscriptome Meta-Analysis (IBD TaMMA) framework 35
Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel disease 34
Forty-Eight Hours of Biopsy Culture Improve the Sensitivity of the in Vitro Gliadin Challenge in the Diagnosis of Celiac Disease 29
Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference 29
Mesalamine in the treatment of mild to moderate active Crohn's ileitis: Results of a randomized, multicenter trial 28
Sphingosine 1-Phosphate Modulation in Inflammatory Bowel Diseases: Keeping Lymphocytes Out of the Intestine 28
Fibrotic Strictures in Crohn’s Disease: Mechanisms and Predictive Factors 28
Fibro-Stenosing Crohn’s Disease: What Is New and What Is Next? 20
Totale 5.698
Categoria #
all - tutte 41.288
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.288


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021744 0 0 0 0 0 244 117 45 162 84 2 90
2021/2022455 27 3 8 77 4 2 12 54 41 38 157 32
2022/20231.103 182 65 96 118 107 85 3 76 184 104 67 16
2023/2024732 57 72 125 72 34 111 32 22 12 19 53 123
2024/20251.226 27 16 7 54 27 139 93 136 159 268 141 159
2025/20261.377 433 210 270 286 122 56 0 0 0 0 0 0
Totale 5.698